Physician profile
Amisha Patel
NPI 1841433075
$12,045.11
in general payments reported to CMS, 2019-2025
24 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,158 · 2020: $810 · 2021: $2,556 · 2022: $713 · 2023: $1,261 · 2024: $1,436 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Travel and Lodging: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,131.99 |
| Travel and Lodging | $1,676.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,570.98 | 2019-2025 | Mitraclip, Diamondback Coronary, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $2,260.69 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,871.87 | 2021-2025 | Corevalve Evolut R, Heli-Fx Endoanchor System |
| Cardiovascular Systems INC. | $1,538.65 | 2019-2022 | |
| Heartflow, INC. | $1,218.33 | 2019-2023 | Ffrct |
| Boston Scientific Corporation | $295.66 | 2019-2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $200.90 | 2019 | |
| Stryker Corporation | $186.41 | 2025 | Clottriever Bold Catheter, Venacore Thrombectomy Catheter, Flowtriever |
| Novartis Pharmaceuticals Corporation | $124.88 | 2024-2025 | |
| Cardiva Medical, INC. | $117.00 | 2019 | |
| Medtronic Vascular, INC. | $114.04 | 2019 | |
| Cordis US Corp. | $103.58 | 2025 | Mynx Control Venous |
| W. L. Gore & Associates, INC. | $67.95 | 2025 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $64.37 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.71 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $42.60 | 2024 | Impella |
| Tactile Systems Technology INC | $39.95 | 2025 | Flexitouch Plus, Nimbl |
| Bard Peripheral Vascular, INC. | $33.89 | 2025 | Lutonix Drug Coated Balloon |
| Amgen INC. | $33.50 | 2021 | |
| Davol INC. | $28.07 | 2025 | Venovo |
| Lexicon Pharmaceuticals, INC. | $22.86 | 2024 | |
| Amarin Pharma, INC. | $20.91 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.20 | 2019 | |
| Cook Medical LLC | $14.11 | 2025 | Zilver Vena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amisha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.